Lung

Advocacy In Action: Lung Cancer Treatment Guidelines and Molecular Testing
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. Joining Selma Schimmel as co-moderators are: David R. Spigel, MD – Director, Lung Cancer Research Program at Sarah Cannon Research Institute and a Medical Oncologist at Tennessee Oncology, PLLC, Nashville, TN Ming S. Tsao, […]

Read More
Advocacy In Action: What If a Patient Is Told They Have No Tumor Marker?
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. This segment asks the question:  What if a patient tests negative for molecular testing and has no tumor marker?  How do you explain to them that this is still personalized medicine? Joining Selma Schimmel […]

Read More
Advocacy In Action: What If Molecular Testing Is Not Offered?
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. This segment asks the question:  If my doctor does not recommend that I have my tumor tested, how do I insist on it and where should I go? Joining Selma Schimmel as co-moderators are: […]

Read More
Advocacy In Action: What Should Patients Expect When Getting Molecular Testing?
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. This segment asks the question:  When a patient is told they need to have their tumor tested, what should they expect? Joining Selma Schimmel as co-moderators are: David R. Spigel, MD – Director, Lung […]

Read More
Advocacy In Action: Who Should Have Molecular Testing When Diagnosed With Lung Cancer?
Jul
10
2013

Vital Options International presents, Advocacy In Action®, bringing together cancer advocacy leadership to address: Lung Cancer Treatment Guidelines & Molecular Testing. This segment asks the question:  Why are only EFR and ALK are tested for and who should be tested? Joining Selma Schimmel as co-moderators are: David R. Spigel, MD – Director, Lung Cancer Research […]

Read More
Benjamin P. Levy, MD: Next Generation Sequencing In Lung Cancer
Jul
08
2013

Dr. Benjamin Levy sits down with Selma Schimmel in The Group Room to discuss next generation sequencing in lung cancer. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2013. Benjamin P. Levy, MD is the Head of Thoracic Medical Oncology, Division of Hematology-Oncology, Beth Israel Medical Center, Continuum […]

Read More
Jonathan Goldman, MD: Immunotherapy and Lung Cancer
Jun
21
2013

Dr. Goldman sits down with Selma Schimmel in The Group Room. They discuss the exciting news in immunotherapy for lung cancer patients. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2013. Jonathan Goldman, MD, Director, Clinical Trials in Thoracic Oncology and Associate Director of Drug Development at UCLA. […]

Read More
Jonathan Goldman, MD: Advanced Lung Cancer Update — ASCO 2013
Jun
21
2013

Dr. Goldman sits down with Selma Schimmel in The Group Room. They discuss news for advanced lung cancer coming out of ASCO 2013.  In addition, they touch on young women, never smoker population who seem to have an increase in lung cancer incidence, and even some news for small cell lung cancer patients. This interview […]

Read More
Jonathan Goldman, MD: Antibody Against MET in Lung Cancer — ASCO 2013
Jun
21
2013

Dr. Goldman sits down with Selma Schimmel in The Group Room. They discuss his poster session on and antibody against the MET receptor. This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2013. Jonathan Goldman, MD, Director, Clinical Trials in Thoracic Oncology and Associate Director of Drug Development at […]

Read More
Kimberly Rohan MS, APN, AOCN : The Role of the Oncology Nurse in Biomarker Testing Education
Oct
29
2012

Kimberly Rohan discusses the role of the oncology nurse in biomarker testing education for those patients newly diagnosed with lung cancer. Kimberly Rohan, MS, APN, AOCN is an Advanced Practice Nurse and an Oncology Clinical Nurse at the Edward Cancer Center in Naperville, Illinois.  She is a member of the Oncology Nursing Society, American Academy […]

Read More